Published on in Vol 7 (2023)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/41055, first published
.
![High-Throughput Assessment of Real-World Medication Effects on QT Interval Prolongation: Observational Study High-Throughput Assessment of Real-World Medication Effects on QT Interval Prolongation: Observational Study](https://asset.jmir.pub/assets/f4f9a476308374599689e3419ddca02d.png 480w,https://asset.jmir.pub/assets/f4f9a476308374599689e3419ddca02d.png 960w,https://asset.jmir.pub/assets/f4f9a476308374599689e3419ddca02d.png 1920w,https://asset.jmir.pub/assets/f4f9a476308374599689e3419ddca02d.png 2500w)
Journals
- Evenepoel P, Jørgensen H. Hypocalcemia: a cardiovascular risk factor coming of age?. Nephrology Dialysis Transplantation 2024;39(4):557 View
- Ouchi R, Nagao M, Suzuki S, Yamagata T, Chiba M, Kurata N, Usui K, Watanabe T, Koyama K, Okada K. A case with a trend of QT interval prolongation due to the introduction of methadone to a pancreatic cancer patient on levofloxacin. Journal of Pharmaceutical Health Care and Sciences 2024;10(1) View
- Hamid A, Pastor Arroyo E, Calvet C, Hewitson T, Muscalu M, Schnitzbauer U, Smith E, Wagner C, Egli-Spichtig D. Phosphate Restriction Prevents Metabolic Acidosis and Curbs Rise in FGF23 and Mortality in Murine Folic Acid–Induced AKI. Journal of the American Society of Nephrology 2024;35(3):261 View